These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2184747)

  • 21. Immunological disorders of type 1 diabetes mellitus.
    Ziegler M; Ziegler B
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DiaPep277® and immune intervention for treatment of type 1 diabetes.
    Schloot NC; Cohen IR
    Clin Immunol; 2013 Dec; 149(3):307-16. PubMed ID: 24090708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current and future care for diabetes in children: from insulin to immunotherapy].
    Dirlewanger M; Hauschild M; Phan-Hug F; Schwitzgebel VM
    Rev Med Suisse; 2011 Feb; 7(283):430-6. PubMed ID: 21452510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.
    Silverstein J; Maclaren N; Riley W; Spillar R; Radjenovic D; Johnson S
    N Engl J Med; 1988 Sep; 319(10):599-604. PubMed ID: 3045545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 1A diabetes induced by infection and immunization.
    Robles DT; Eisenbarth GS
    J Autoimmun; 2001 May; 16(3):355-62. PubMed ID: 11334504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D.
    Boettler T; von Herrath M
    Int Immunopharmacol; 2010 Dec; 10(12):1491-5. PubMed ID: 20667487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty--TEENDIAB: study design.
    Ziegler AG; Meier-Stiegen F; Winkler C; Bonifacio E;
    Pediatr Diabetes; 2012 Aug; 13(5):419-24. PubMed ID: 21446926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular biological aspects of the pathogenesis of diabetes mellitus].
    Pankov IuA; Chekhranova MK; Keda IuM; Gorskova VA; Kondrat'ev IaIu
    Vestn Akad Med Nauk SSSR; 1989; (5):5-17. PubMed ID: 2667269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive therapy for diabetes mellitus.
    Werther GA
    Aust Paediatr J; 1985 Nov; 21(4):247-8. PubMed ID: 3911935
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological aspects of diabetes.
    Cheţa D
    Recenti Prog Med; 1990 Feb; 81(2):72-8. PubMed ID: 2195611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes.
    Kroger CJ; Clark M; Ke Q; Tisch RM
    Front Immunol; 2018; 9():1891. PubMed ID: 30166987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?
    Kakka R; Koda-Kimble MA
    Pharmacotherapy; 1997; 17(1):38-44. PubMed ID: 9017764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune markers of type-I diabetes mellitus in children with diabetes in their first-degree relatives. Part I].
    Buczkowska EO; Chobot PJ
    Przegl Lek; 2003; 60(9):580-4. PubMed ID: 15065337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse and man: multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders.
    Gottlieb PA; Eisenbarth GS
    J Autoimmun; 1996 Apr; 9(2):277-81. PubMed ID: 8738974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothesis for the pathogenesis of type 1A diabetes.
    Jasinski JM; Eisenbarth GS
    Drugs Today (Barc); 2005 Feb; 41(2):141-9. PubMed ID: 15821785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type I diabetes masquerading as type II diabetes. Possible implications for prevention and treatment.
    Leslie RD; Pozzilli P
    Diabetes Care; 1994 Oct; 17(10):1214-9. PubMed ID: 7821148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.